Journal Article

MicroRNA-301a/ZNRF3/wnt/β-catenin signal regulatory crosstalk mediates glioma progression

Ma, Quanfeng, Shu, Chang, Li, Banban, Zhang, Shusheng, Li, Jialin, Xiong, Jinbiao, Sun, Jikui, Wu, Jingchao, Wang, Jinhuan, Liu, Jun

2021

Overview

MicroRNA (miR)-mediated mRNA and multiple signaling pathway dysregulations have been extensively implicated in several cancer types, including gliomas. Although previous studies have reported that miR-301a acts as an oncogene, the underlying mechanisms of miR-301a in the initiation and progression of glioma remain unknown. The present study aimed to investigate the involvement of miR-301a-mediated signaling pathway dysregulation in glioma. The results identified that miR-301a was significantly upregulated in gliomas and was associated with a poor prognosis based on The Cancer Genome Atlas and Chinese Glioma Genome Atlas databases. Moreover, zinc and ring finger 3 (ZNRF3) exerted a critical role in the miR-301a-mediated effects on the malignant phenotype, such as by affecting proliferation and apoptosis. Mechanistically, the TOP/FOP luciferase assay, western blotting and immunofluorescence results demonstrated that miR-301a knockdown inhibited the wnt/β-catenin signaling pathway, at least partially via ZNRF3, while ZNRF3 was a direct functional target of miR-301a, as indicated by luciferase reporter assay and western blot analysis. Furthermore, ZNRF3 could in turn repress miR-301a expression, which was dependent on the wnt pathway. Collectively, the present study identified a novel miR-301a/ZNRF3/wnt/β-catenin signaling feedback loop that serves critical roles in glioma tumorigenesis, and that may represent a potential therapeutic target.

• Publisher: D.A. Spandidos,Spandidos Publications UK Ltd
• Subject: Age / Apoptosis / Binding sites / Brain cancer / Cancer therapies / Experiments / Gene expression / Glioma / microRNA-301a / MicroRNAs / Plasmids / Reagents / transcription factor 4 / Transcription factors / wnt/β-catenin / ZNRF3